OMNI Peptides score history

Score over time

Every entry newest first

1. October 29, 2026Raised from6.06→to6.17(+0.11)

   Core products recomputed on 29 October 2026 (rule A1b): listings added for newly reviewed vendors made NAD+ a core product in place of CJC-1295, so a missing certificate for each now counts at its new weight: lab 6.5 to 6.7.

2. October 27, 2026Lowered from6.08→to6.06(-0.02)

   Market medians updated after S1Research was added pricing 5.1 to 5.0.

3. October 27, 2026Raised from6.06→to6.08(+0.02)

   Pricing recomputed on 27 October 2026: listings added for a newly reviewed vendor (Peptide Pro) moved the market median for the same products pricing 5.0 to 5.1.

4. October 27, 2026Lowered from6.08→to6.06(-0.02)

   Pricing recomputed on 27 October 2026: listings added for a newly reviewed vendor (NovaForge Labs) moved the market median for the same products: pricing 5.1 to 5.0.

5. October 25, 2026Lowered from6.09→to6.08(-0.01)

   Pricing recomputed on 25 October 2026: listings added for a newly reviewed vendor (Pexo Labs) moved the market median for the same products: pricing 5.2 to 5.1.

6. October 24, 2026Lowered from6.12→to6.09(-0.03)

   Pricing recomputed on 24 October 2026 after Bionova Peptides' first-review prices were recorded; other vendors move only through the market medians: pricing 5.4 to 5.2.

7. October 24, 2026Raised from6.09→to6.12(+0.03)

   Pricing recomputed on 24 October 2026: listings added for newly reviewed vendors moved the market median for the same products: pricing 5.2 to 5.4.

8. October 23, 2026Lowered from6.11→to6.09(-0.02)

   Pricing recomputed on 23 October 2026 under the revised rule E1 (standing offers), which prices a size at the lowest total a buyer can pay without a code under standing prices, so a standing offer that includes a second vial at no extra cost now counts at all the milligrams received, in the vendor's own price and in the market medians for the same products: pricing 5.3 to 5.2.

9. October 23, 2026Lowered from6.12→to6.11(-0.01)

   Pricing recomputed on 23 October 2026 from current listings with the published rule (section E), after listings added or updated since 22 October, including a newly reviewed vendor's, moved the market median for the same products: pricing 5.4 to 5.3.

10. October 22, 2026Raised from5.79→to6.12(+0.33)

    Lab score recalculated on 22 October 2026 under the published core-product rule (A1b): a missing certificate on one of the 15 most widely carried products still counts fully, while on any other product it now counts at half weight, so a broad catalogue is not penalised as much for its breadth. Lab 5.9 to 6.5.

11. October 22, 2026Raised from5.72→to5.79(+0.07)

    Re-scored on 22 October 2026 under our published rubric for shipping, pricing, operating history and transparency, applied to every vendor the same day: prices re-read from the vendor's site and matched by milligrams per vial, operating history from the earliest dated evidence of the business, and policies scored item by item. shipping and refunds 6.0 to 7.0, transparency 5.5 to 3.0.

12. October 22, 2026Lowered from5.77→to5.72(-0.05)

    Re-scored on 22 October 2026 under our published rubric for shipping, pricing, operating history and transparency, applied to every vendor the same day: prices re-read from the vendor's site and matched by milligrams per vial, operating history from the earliest dated evidence of the business, and policies scored item by item. pricing 6.5 to 5.4, operating history 1.5 to 3.7.

13. October 21, 2026Lowered from6.38→to5.77(-0.61)

    Lab evidence re-checked on 20 October 2026 under our coverage rule, which counts a listed product with no published certificate as zero in the lab average. Certificates cover 12 of the 17 products we list that the vendor offers for sale. Lab 7.0 to 5.9.

14. October 15, 2026First publishedat6.38

    lab 7.0 / shipping 6.0 / pricing 6.5 / tenure 1.5 / transparency 5.5.